Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart.
Saved in:
| Title: | Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart. |
|---|---|
| Authors: | Van de Walle I; argenx, Ghent, Belgium. IVandeWalle@argenx.com., Bracke L; argenx, Ghent, Belgium., Olesen HG; Department of Molecular Biology and Genetics - Protein Science, Universitetsbyen 81, 8000, Aarhus C, Denmark., van Bragt T; Curare Consulting BV, Liempde, The Netherlands., Cadour S; argenx, Ghent, Belgium., De Decker P; argenx, Ghent, Belgium., Ciurlia G; argenx, Ghent, Belgium., Pannecoucke E; argenx, Ghent, Belgium., Persson EK; argenx, Ghent, Belgium., Van de Steen O; argenx, Ghent, Belgium., Leng X; argenx, Ghent, Belgium., Andersen GR; Department of Molecular Biology and Genetics - Protein Science, Universitetsbyen 81, 8000, Aarhus C, Denmark., Gandini D; argenx, Ghent, Belgium., Hack CE; argenx, Ghent, Belgium. |
| Source: | Nature communications [Nat Commun] 2025 Aug 16; Vol. 16 (1), pp. 7639. Date of Electronic Publication: 2025 Aug 16. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40819168 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Van+de+Walle+I%22">Van de Walle I</searchLink>; argenx, Ghent, Belgium. IVandeWalle@argenx.com.<br /><searchLink fieldCode="AU" term="%22Bracke+L%22">Bracke L</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Olesen+HG%22">Olesen HG</searchLink>; Department of Molecular Biology and Genetics - Protein Science, Universitetsbyen 81, 8000, Aarhus C, Denmark.<br /><searchLink fieldCode="AU" term="%22van+Bragt+T%22">van Bragt T</searchLink>; Curare Consulting BV, Liempde, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Cadour+S%22">Cadour S</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Decker+P%22">De Decker P</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Ciurlia+G%22">Ciurlia G</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Pannecoucke+E%22">Pannecoucke E</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Persson+EK%22">Persson EK</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+de+Steen+O%22">Van de Steen O</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Leng+X%22">Leng X</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Andersen+GR%22">Andersen GR</searchLink>; Department of Molecular Biology and Genetics - Protein Science, Universitetsbyen 81, 8000, Aarhus C, Denmark.<br /><searchLink fieldCode="AU" term="%22Gandini+D%22">Gandini D</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Hack+CE%22">Hack CE</searchLink>; argenx, Ghent, Belgium. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Aug 16; Vol. 16 (1), pp. 7639. <i>Date of Electronic Publication: </i>2025 Aug 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40819168 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-025-62925-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 7639 Titles: – TitleFull: Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Van de Walle I – PersonEntity: Name: NameFull: Bracke L – PersonEntity: Name: NameFull: Olesen HG – PersonEntity: Name: NameFull: van Bragt T – PersonEntity: Name: NameFull: Cadour S – PersonEntity: Name: NameFull: De Decker P – PersonEntity: Name: NameFull: Ciurlia G – PersonEntity: Name: NameFull: Pannecoucke E – PersonEntity: Name: NameFull: Persson EK – PersonEntity: Name: NameFull: Van de Steen O – PersonEntity: Name: NameFull: Leng X – PersonEntity: Name: NameFull: Andersen GR – PersonEntity: Name: NameFull: Gandini D – PersonEntity: Name: NameFull: Hack CE IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 08 Text: 2025 Aug 16 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |